CRL Earnings

Quarterly EPS
$1.34
Q3 2024
$-4.22
Q4 2024
$0.50
Q1 2025
$1.06
Q2 2025
$1.11
Q3 2025
$-5.62
Q4 2025
$-0.30
Q1 2026
$-0.03
Q2 2026
Latest Revenue1.0B
Latest Net Income-760000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.031.0B-760000-2.7%-102.8%
Q1 2026-$0.30995.8M-14802000+1.2%-160.0%
Q4 2025-$5.62994.2M-276290000-0.8%-33.2%
Q3 2025$1.111.0B55.6M-0.5%-17.2%
Q2 2025$1.061.0B52.7M+0.6%-39.4%
Q1 2025$0.50984.2M25.9M-2.7%-61.8%
Q4 2024-$4.221.0B-213747000-1.1%-215.6%
Q3 2024$1.341.0B70.3M-1.6%-21.2%
Q2 2024$1.751.0B94.3M
Q1 2024$1.311.0B74.5M
Q4 2023$3.651.0B189.0M
Q3 2023$1.701.0B88.0M
Charles River Laboratories International (CRL) — Earnings